Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
A new, safe, and effective vaccine against poliovirus is urgently needed not only to complete the eradication of the virus but also to be used in the future to prevent possible virus reemergence in a postpolio world. Currently, new formulations of the oral vaccine, as well as improvements to the inactivated vaccine, are being explored. In this study, we designed a viral vector with mucosal tropism that expresses poliovirus capsid proteins. Thus, poliovirus VLPs are produced in vivo , in the cells of a vaccine recipient, and are presented to the immune system in the context of vector virus replication, stimulating the development of systemic and mucosal immune responses. Such an approach allows the development of an affordable and safe vaccine that does not rely on the full-length poliovirus genome at any stage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In recent years, PV VLPs with native antigenicity have been produced in various systems, including mammalian cells, plants, insects, bacteria and yeast [129,131,132,133,134,135,136].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [129]
Citations
Cites
2 retracted
Khattar, S. K., Samal, S., DeVico, A. L., Collins, P. L., & Samal, S. K. (2011) · Journal of Virology · doi:10.1128/jvi.05050-11 · Cited by 37 · cited 1×
“Previous research indicates that the immune response of guinea pigs to NDV vector-based vaccines resembles that observed in primate models (31, 38, 39).”
ResultSelf-citationRetractedExperimental infection of hamsters with avian paramyxovirus serotypes 1 to 9
Samuel, A. S., Subbiah, M., Shive, H. R., Collins, P. L., & Samal, S. K. (2011) · Veterinary Research · doi:10.1186/1297-9716-42-38 · Cited by 36 · cited 1×
“Rabbit polyclonal antibodies against NDV NP protein have been described previously (74), and mouse monoclonal antibodies against NDV HN were a kind gift from Shin-Hee Kim (University of Maryland).”
MethodSelf-citationRetractedBradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“Prior to the antibody assay and microneutralization test, the protein concentrations of vaginal wash samples were determined by the Bradford protocol (76).”
MethodGuide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche
Kärber, G. (1931) · Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01863914 · Cited by 3,104 · cited 1×
“Poliovirus type 1 Mahoney was propagated in HeLa cells, and the viral titer was either determined by a plaque assay and expressed as PFU per milliliter (for experiments where expression of poliovirus proteins was assessed) or determined by the terminal dilution method and expressed as 50% tissue culture infective dose…”
MethodGuide for the Care and Use of Laboratory Animals (8th edn)
Albus, U. (2012) · Laboratory Animals · doi:10.1258/la.2012.150312 · Cited by 1,693
Henao-Restrepo, A. M., Camacho, A., Longini, I. M., Watson, C. H., Edmunds, W. J., Egger, M., Carroll, M. W., Dean, N. E., Diatta, I., Doumbia, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32621-6 · Cited by 1,110
Phase I/II Trial of Intravenous NDV-HUJ Oncolytic Virus in Recurrent Glioblastoma Multiforme
Freeman, A. I., Zakay-Rones, Z., Gomori, J. M., Linetsky, E., Rasooly, L., Greenbaum, E., Rozenman-Yair, S., Panet, A., Libson, E., Irving, C. S., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.016 · Cited by 407 · cited 1×
“Moreover, NDV has been explored as an oncolytic virus and demonstrated an excellent safety profile in clinical trials, even when high doses of the virus were administered intravenously to individuals with compromised immune systems (30).”
BackgroundImmunoglobulin Responses at the Mucosal Interface
Cerutti, A., Chen, K., & Chorny, A. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101317 · Cited by 395
Garbutt, M., Liebscher, R., Wahl-Jensen, V., Jones, S., Möller, P., Wagner, R., Volchkov, V., Klenk, H.-D., Feldmann, H., & Ströher, U. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5458-5465.2004 · Cited by 381 · cited 1×
“The recent rapid deployment and success of a vesicular stomatitis virus (VSV)-based vectored vaccine against Ebola virus demonstrates that such an approach to vaccine evaluation is warranted and proves the clinical relevance of a vectored vaccine with a design similar to that described in this study (67, 68).”
Method
Research works printed but not linked: 3
- Lamb RA, Parks GD. 2007. Paramyxoviridae: the viruses and their replication, p 1449–1496. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
- Samal SK. 2011. The biology of paramyxoviruses, p 69–114. Caister Academic Press, Norfolk, United Kingdom.
- . 1997. Manual for the virological investigation of polio. World Health Organization, Geneva, Switzerland.
Cited by
McCann, N. S., O’Connor, D., Lambe, T., & Pollard, A. J. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102210 · Cited by 146
Hu, Z., Ni, J., Cao, Y., & Liu, X. (2020) · Vaccines · doi:10.3390/vaccines8020222 · Cited by 62
“Two human vaccine candidates based on NDV against poliovirus and Japanese encephalitis virus were generated and these vaccines were immunogenic in animal models [91,95].”
BackgroundViruses as tools in gene therapy, vaccine development, and cancer treatment
bin Umair, M., Fujimura, N. A., Kashif, H., Seerat-e-Fatima, Butt, F., Azhar, M., Munir, I., Ahmed, M. I., Khalil, W., Sharyar, H., et al. (2022) · Archives of Virology · doi:10.1007/s00705-022-05432-8 · Cited by 54
“Another study demonstrated the stimulation of host immunity against poliomyelitis virus by injection with rNDV expressing the poliovirus precursor capsid protein and the associated protease [162].”
BackgroundFulber, J. P. C., & Kamen, A. (2022) · Viruses · doi:10.3390/v14050975 · Cited by 37
“Vaccine Type Pathogen Disease Antigen Expressed Animal Model Production Platform * Route * Dose * Reference Live LaSota strain H7N9, H5N1 Respiratory infection HA Chicken ECEs im, on two doses of 5 × 106 PFU [128] Live LaSota strain VSV Vesicular stomatitis G Mouse ECEs im two doses of 1 × 107 TCID50 [129] Live LaSota…”
BackgroundInfluentialThe Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
Metadata
- Authors
- Viktorova, E. G., Khattar, S. K., Kouiavskaia, D., Laassri, M., Zagorodnyaya, T., Dragunsky, E., Samal, S., Chumakov, K., & Belov, G. A.
- Affiliations
- Virginia–Maryland College of Veterinary Medicine (US)
- Center for Biologics Evaluation and Research (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2018-09
- Volume
- 92
- Issue
- 17
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC6096817
- OpenAlex
- W2808156154
- Cited by
- 29
- References
- 78
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 10 · 2021: 1 · 2020: 4
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | National Institutes of Health (R21AI15383A)
- Topics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- Newcastle disease virus vector, polio vaccine, poliovirus, virus-like particles, capsid protein, mucosal immunity, systemic immune response, live attenuated vaccine, vaccine safety
- MeSH terms
- Animals, Antibodies, Viral, Genetic Vectors, Guinea Pigs, Immunoglobulin A, Immunoglobulin G, Newcastle disease virus, Poliomyelitis, Poliovirus Vaccine, Inactivated, Vaccination, Poliovirus, Immunity, Mucosal, Poliovirus Vaccines, Capsid Proteins, Vaccines, Virus-Like Particle, Vaccines, Live, Unattenuated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis. https://app.cochat.ai/papers/10.1128/jvi.00976-18
- The paper
- Viktorova, E. G., Khattar, S. K., Kouiavskaia, D., Laassri, M., Zagorodnyaya, T., Dragunsky, E., Samal, S., Chumakov, K., & Belov, G. A. (2018). Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis. Journal of Virology. https://doi.org/10.1128/jvi.00976-18
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.